scholarly article | Q13442814 |
P2093 | author name string | Kushner PJ | |
Parker MG | |||
Cavailles V | |||
Lopez G | |||
Webb P | |||
Baxter JD | |||
Fitzpatrick PM | |||
Gizang-Ginsberg E | |||
Sadovsky Y | |||
P2860 | cites work | Human TAFII30 is present in a distinct TFIID complex and is required for transcriptional activation by the estrogen receptor | Q24321811 |
The activation domain of transcription factor PU.1 binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB | Q24563487 | ||
The cloned human oestrogen receptor contains a mutation which alters its hormone binding properties | Q24567487 | ||
c-Fos-induced activation of a TATA-box-containing promoter involves direct contact with TATA-box-binding protein | Q24609940 | ||
Crystal structure of a yeast TBP/TATA-box complex | Q27732067 | ||
Co-crystal structure of TBP recognizing the minor groove of a TATA element | Q27732068 | ||
Single-step purification of polypeptides expressed in Escherichia coli as fusions with glutathione S-transferase | Q27860571 | ||
Functional domains and upstream activation properties of cloned human TATA binding protein | Q28116604 | ||
Crystal structure of TFIID TATA-box binding protein | Q28202669 | ||
Direct interaction of human TFIID with the HIV-1 transactivator tat | Q28250314 | ||
Estrogen receptor-associated proteins: possible mediators of hormone-induced transcription | Q28254487 | ||
Members of the steroid hormone receptor superfamily interact with TFIIB (S300-II) | Q28264307 | ||
Isolation of coactivators associated with the TATA-binding protein that mediate transcriptional activation | Q28303864 | ||
GAL4-VP16 is an unusually potent transcriptional activator | Q29616453 | ||
Identification of a conserved region required for hormone dependent transcriptional activation by steroid hormone receptors | Q29616455 | ||
Transcriptional activation: a complex puzzle with few easy pieces | Q29616518 | ||
The human estrogen receptor has two independent nonacidic transcriptional activation functions | Q29617089 | ||
Molecular cloning and functional analysis of Drosophila TAF110 reveal properties expected of coactivators | Q29620376 | ||
Distinct TFIID complexes mediate the effect of different transcriptional activators | Q34043048 | ||
A glutamine-rich hydrophobic patch in transcription factor Sp1 contacts the dTAFII110 component of the Drosophila TFIID complex and mediates transcriptional activation | Q34920038 | ||
Interaction of proteins with transcriptionally active estrogen receptors | Q35827947 | ||
Expression and analysis of the human cytomegalovirus UL80-encoded protease: identification of autoproteolytic sites | Q36640105 | ||
Functional interaction of the v-Rel and c-Rel oncoproteins with the TATA-binding protein and association with transcription factor IIB. | Q36824974 | ||
Direct interaction between adenovirus E1A protein and the TATA box binding transcription factor IID | Q37531197 | ||
Synergism between Tat and VP16 in trans-activation of HIV-1 LTR. | Q38313551 | ||
Association between proto-oncoprotein Rel and TATA-binding protein mediates transcriptional activation by NF-kappa B. | Q38315744 | ||
Positive and negative modulation of Jun action by thyroid hormone receptor at a unique AP1 site | Q38319606 | ||
Holo-TFIID supports transcriptional stimulation by diverse activators and from a TATA-less promoter | Q38325574 | ||
Interference between pathway-specific transcription factors: glucocorticoids antagonize phorbol ester-induced AP-1 activity without altering AP-1 site occupation in vivo | Q38328562 | ||
Identification of a tumor necrosis factor-responsive element in the tumor necrosis factor alpha gene | Q38335180 | ||
Transcriptional selectivity of viral genes in mammalian cells | Q39743207 | ||
Different TBP-associated factors are required for mediating the stimulation of transcription in vitro by the acidic transactivator GAL-VP16 and the two nonacidic activation functions of the estrogen receptor. | Q40404523 | ||
The core promoter region of the tumor necrosis factor alpha gene confers phorbol ester responsiveness to upstream transcriptional activators. | Q40678312 | ||
Eukaryotic regulatory elements lurking in plasmid DNA: the activator protein-1 site in pUC. | Q40683989 | ||
Cooperativity in vivo between the E2 transactivator and the TATA box binding protein depends on core promoter structure. | Q40790439 | ||
A C-terminal domain in FosB, absent in FosB/SF and Fra-1, which is able to interact with the TATA binding protein, is required for altered cell growth. | Q40792892 | ||
Functional and biochemical interaction of the HTLV-I Tax1 transactivator with TBP. | Q40874297 | ||
Synergistic activation of transcription by the human estrogen receptor bound to tandem responsive elements | Q41218711 | ||
Residues in the TATA-binding protein required to mediate a transcriptional response to retinoic acid in EC cells | Q41521246 | ||
Cooperativity in transactivation between retinoic acid receptor and TFIID requires an activity analogous to E1A | Q41627610 | ||
The limits of the cellular capacity to mediate an estrogen response | Q41641372 | ||
Construction of cell lines that express high levels of the human estrogen receptor and are killed by estrogens | Q41719574 | ||
TFIID can be rate limiting in vivo for TATA-containing, but not TATA-lacking, RNA polymerase II promoters | Q42468186 | ||
Coactivators for a proline-rich activator purified from the multisubunit human TFIID complex | Q42468497 | ||
Assembly of recombinant TFIID reveals differential coactivator requirements for distinct transcriptional activators | Q42491732 | ||
Drosophila TAFII40 interacts with both a VP16 activation domain and the basal transcription factor TFIIB. | Q42502083 | ||
Adenovirus E1A activation domain binds the basic repeat in the TATA box transcription factor | Q46050449 | ||
Initiation of transcription by RNA polymerase II: a multi-step process. | Q52545755 | ||
Reduced binding of TFIID to transcriptionally compromised mutants of VP16. | Q54251780 | ||
Stringent spacing requirements for transcription activation by CRP. | Q54709893 | ||
Eukaryotic activators function during multiple steps of preinitiation complex assembly | Q59058665 | ||
Direct and selective binding of an acidic transcriptional activation domain to the TATA-box factor TFIID | Q59070657 | ||
Negative effect of the transcriptional activator GAL4 | Q59072863 | ||
Evidence for interaction of different eukaryotic transcriptional activators with distinct cellular targets | Q59098114 | ||
Steroid hormone receptors compete for factors that mediate their enhancer function | Q61818663 | ||
Functional interaction of adenovirus E1A with holo-TFIID | Q64377679 | ||
Functional domains of the human estrogen receptor | Q69466265 | ||
A simple method to determine whole cell uptake of radiolabelled oestrogen and progesterone and their subcellular localization in breast cancer cell lines in monolayer culture | Q70792651 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | overexpression | Q61643320 |
P304 | page(s) | 1554-1563 | |
P577 | publication date | 1995-03-01 | |
P1433 | published in | Molecular and Cellular Biology | Q3319478 |
P1476 | title | Transcriptional activators differ in their responses to overexpression of TATA-box-binding protein | |
P478 | volume | 15 |
Q39726423 | 17Beta-estradiol enhances leptin expression in human placental cells through genomic and nongenomic actions |
Q90727042 | A Metastable Contact and Structural Disorder in the Estrogen Receptor Transactivation Domain |
Q24292390 | A negative coregulator for the human ER |
Q34462531 | A novel domain within the DEAD-box protein DP103 is essential for transcriptional repression and helicase activity |
Q38347273 | AF-2 activity and recruitment of steroid receptor coactivator 1 to the estrogen receptor depend on a lysine residue conserved in nuclear receptors |
Q89731178 | Abnormal expression of TFIIIB subunits and RNA Pol III genes is associated with hepatocellular carcinoma |
Q34509209 | Alcohol Induces RNA Polymerase III-dependent Transcription through c-Jun by Co-regulating TATA-binding Protein (TBP) and Brf1 Expression |
Q41052367 | An Sp1-binding silencer element is a critical negative regulator of the megakaryocyte-specific alphaIIb gene |
Q46099211 | An antiestrogen-responsive estrogen receptor-alpha mutant (D351Y) shows weak AF-2 activity in the presence of tamoxifen |
Q43705564 | An isoform of the coactivator AIB1 that increases hormone and growth factor sensitivity is overexpressed in breast cancer. |
Q38304746 | Binding of TATA binding protein to a naturally positioned nucleosome is facilitated by histone acetylation |
Q42445040 | Binding of the thyroid hormone receptor to a negative element in the basal growth hormone promoter is associated with histone acetylation |
Q39725073 | Biochemical and genetic characterization of the dominant positive element driving transcription ofthe yeast TBP-encoding gene, SPT15. |
Q37376082 | CREB binding protein acts synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent transcription |
Q24685873 | CREB-binding protein in androgen receptor-mediated signaling |
Q37825449 | Chemical biology of histone acetyltransferase natural compounds modulators |
Q22009068 | Cloning and characterization of human prostate coactivator ARA54, a novel protein that associates with the androgen receptor |
Q41735775 | Coactivator-vitamin D receptor interactions mediate inhibition of the atrial natriuretic peptide promoter |
Q35870943 | Constitutive retinoid receptors expressed from adenovirus vectors that specifically activate chromosomal target genes required for differentiation of promyelocytic leukemia and teratocarcinoma cells |
Q40999474 | Control of transcription by steroid hormones |
Q41687354 | Cooperative assembly of androgen receptor into a nucleoprotein complex that regulates the prostate-specific antigen enhancer. |
Q34100653 | Cooperative coactivation of estrogen receptor alpha in ZR-75 human breast cancer cells by SNURF and TATA-binding protein |
Q38343591 | Different estrogen receptor structural domains are required for estrogen- and tamoxifen-dependent anti-proliferative activity in human mammary epithelial cells expressing an exogenous estrogen receptor |
Q24315063 | Differential interaction of nuclear receptors with the putative human transcriptional coactivator hTIF1 |
Q38101203 | Dysregulation of the basal RNA polymerase transcription apparatus in cancer |
Q41472140 | Elevated TATA-binding protein expression drives vascular endothelial growth factor expression in colon cancer |
Q35084786 | Endocrine-responsive breast cancer and strategies for combating resistance |
Q37075889 | Enforcing the pause: transcription factor Sp3 limits productive elongation by RNA polymerase II. |
Q40550738 | Epidermal growth factor enhances cellular TATA binding protein levels and induces RNA polymerase I- and III-dependent gene activity |
Q39949595 | Epidermal growth factor receptor 1 (EGFR1) and its variant EGFRvIII regulate TATA-binding protein expression through distinct pathways |
Q28245969 | Estrogen receptor alpha in human breast cancer: occurrence and significance |
Q60956059 | Estrogen receptor binding to estrogen response elements slows ligand dissociation and synergistically activates reporter gene expression |
Q28140995 | Estrogen receptor interaction with co-activators and co-repressors |
Q38301893 | Estrogen response element sequence impacts the conformation and transcriptional activity of estrogen receptor alpha |
Q52580083 | Estrogen-induced and TAFII30-mediated gene repression by direct recruitment of the estrogen receptor and co-repressors to the core promoter and its reversal by tamoxifen. |
Q44912912 | Functional domain and motif analyses of androgen receptor coregulator ARA70 and its differential expression in prostate cancer |
Q24600501 | GRIP1, a novel mouse protein that serves as a transcriptional coactivator in yeast for the hormone binding domains of steroid receptors |
Q24646387 | GRIP1, a transcriptional coactivator for the AF-2 transactivation domain of steroid, thyroid, retinoid, and vitamin D receptors |
Q36573780 | Hepatitis B virus X protein induces RNA polymerase III-dependent gene transcription and increases cellular TATA-binding protein by activating the Ras signaling pathway |
Q33967804 | Heterozygous disruption of the TATA-binding protein gene in DT40 cells causes reduced cdc25B phosphatase expression and delayed mitosis. |
Q24324051 | Human TAF(II28) promotes transcriptional stimulation by activation function 2 of the retinoid X receptors |
Q40756093 | IFN-Stimulated transcription through a TBP-free acetyltransferase complex escapes viral shutoff |
Q39745952 | Increased expression of TATA-binding protein, the central transcription factor, can contribute to oncogenesis. |
Q38358751 | Increased interaction of proteins in nuclear extract from mouse liver and lung tumors with TATA-containing oligonucleotide |
Q74088870 | Interaction between the retinoid X receptor and transcription factor IIB is ligand-dependent in vivo |
Q24532913 | Isoforms of steroid receptor co-activator 1 differ in their ability to potentiate transcription by the oestrogen receptor |
Q28586142 | Isolation of mouse TFIID and functional characterization of TBP and TFIID in mediating estrogen receptor and chromatin transcription |
Q28307445 | Ligand-dependent interaction between the estrogen receptor and the human homologues of SWI2/SNF2 |
Q24595709 | Ligand-independent recruitment of steroid receptor coactivators to estrogen receptor by cyclin D1 |
Q28219317 | Loricrin expression in cultured human keratinocytes is controlled by a complex interplay between transcription factors of the Sp1, CREB, AP1, and AP2 families |
Q30887023 | MBDin, a novel MBD2-interacting protein, relieves MBD2 repression potential and reactivates transcription from methylated promoters. |
Q40984771 | Metabolically independent and accurately adjustable Aspergillus sp. expression system |
Q34185295 | Molecular structure and biological function of the cancer-amplified nuclear receptor coactivator SRC-3/AIB1. |
Q24323091 | Nuclear factor RIP140 modulates transcriptional activation by the estrogen receptor |
Q33956069 | PATZ attenuates the RNF4-mediated enhancement of androgen receptor-dependent transcription |
Q24554468 | Purification and identification of p68 RNA helicase acting as a transcriptional coactivator specific for the activation function 1 of human estrogen receptor alpha |
Q27935712 | Quantitative imaging of TATA-binding protein in living yeast cells |
Q24648012 | RIP-140 interacts with multiple nuclear receptors by means of two distinct sites |
Q33781677 | Regulation of RNA polymerase I-dependent promoters by the hepatitis B virus X protein via activated Ras and TATA-binding protein |
Q42498731 | Regulation of the estrogen-responsive pS2 gene in MCF-7 human breast cancer cells |
Q33837314 | Selective oestrogen receptor modulation: molecular pharmacology for the millennium |
Q73534497 | Selective oestrogen receptor modulation: molecular pharmacology for the millennium |
Q34312263 | Specific mutations in the estrogen receptor change the properties of antiestrogens to full agonists |
Q39583958 | Stepwise recruitment of components of the preinitiation complex by upstream activators in vivo |
Q24537137 | Structure and function of steroid receptor AF1 transactivation domains: induction of active conformations |
Q36300660 | Synergistic and promoter-selective activation of transcription by recruitment of transcription factors TFIID and TFIIB. |
Q39446445 | Synergistic transcriptional activation by TATA-binding protein and hTAFII28 requires specific amino acids of the hTAFII28 histone fold |
Q34280124 | Synergy among nuclear receptor coactivators: selective requirement for protein methyltransferase and acetyltransferase activities |
Q45422778 | TATA-binding protein and TBP-associated factors during herpes simplex virus type 1 infection: localization at viral DNA replication sites |
Q36564258 | TATA-binding protein is limiting for both TATA-containing and TATA-lacking RNA polymerase III promoters in Drosophila cells |
Q35641709 | TBP is differentially regulated by c-Jun N-terminal kinase 1 (JNK1) and JNK2 through Elk-1, controlling c-Jun expression and cell proliferation |
Q24654017 | TLS inhibits RNA polymerase III transcription |
Q28909277 | The N-terminal regions of estrogen receptor alpha and beta are unstructured in vitro and show different TBP binding properties |
Q41756430 | The estrogen receptor gene: promoter organization and expression |
Q34997521 | The expression and localization of N-myc downstream-regulated gene 1 in human trophoblasts |
Q30164406 | The focal adhesion protein vinexin alpha regulates the phosphorylation and activity of estrogen receptor alpha |
Q38288596 | The hepatitis B virus X protein increases the cellular level of TATA-binding protein, which mediates transactivation of RNA polymerase III genes. |
Q35201383 | The histone acetylase PCAF is a nuclear receptor coactivator. |
Q44061142 | The transcriptional activator GAL4-VP16 regulates the intra-molecular interactions of the TATA-binding protein |
Q24649917 | Three functional classes of transcriptional activation domain |
Q33964554 | Transcriptional regulation of the TATA-binding protein by Ras cellular signaling |
Q34610377 | Transcriptional repression by Rev-erbA alpha is dependent on the signature motif and helix 5 in the ligand binding domain: silencing does not involve an interaction with N-CoR. |
Q38307076 | Unique protein determinants of the subtype-selective ligand responses of the estrogen receptors (ERalpha and ERbeta ) at AP-1 sites |
Q73728723 | [Activation of transcription in eukaryotic cells: interactions between transcription factors and components of the basal transcriptional mechanism] |
Q60956099 | hsp70 is not required for high affinity binding of purified calf uterine estrogen receptor to estrogen response element DNA in Vitro |
Q35189958 | p300 and estrogen receptor cooperatively activate transcription via differential enhancement of initiation and reinitiation |
Q33899255 | p300 and p300/cAMP-response element-binding protein-associated factor acetylate the androgen receptor at sites governing hormone-dependent transactivation |
Search more.